Karcher H - Search Results

1

One-Year Brolucizumab Outcomes in Neovascular Age-Related Macular Degeneration from a Large United States Cohort in the IRIS® Registry.

MacCumber MW, Wykoff CC, Karcher H, Adiguzel E, Sinha SB, Vishwakarma S, LaPrise A, Igwe F, Freitas R, Ip MS, Zarbin MA. MacCumber MW, et al. Among authors: karcher h. Ophthalmology. 2023 Sep;130(9):937-946. doi: 10.1016/j.ophtha.2023.04.012. Epub 2023 Apr 21. Ophthalmology. 2023. PMID: 37086857

2

The Treatment Patterns with Brolucizumab in Germany (REALIZE) Study: A Retrospective Cohort Study Based on Longitudinal Prescription Data.

Liegl RG, Karcher H, Chetty-Mhlanga S, Igwe F, Freitas R. Liegl RG, et al. Among authors: karcher h. Ophthalmol Ther. 2023 Feb;12(1):195-208. doi: 10.1007/s40123-022-00596-7. Epub 2022 Nov 3. Ophthalmol Ther. 2023. PMID: 36327000 Free PMC article.

3

Switching to brolucizumab: injection intervals and visual, anatomical and safety outcomes at 12 and 18 months in real-world eyes with neovascular age-related macular degeneration.

Coney JM, Zubricky R, Sinha SB, Sonbolian N, Zhou L, Hull TP, Lewis SA, Miller DG, Novak MA, Pendergast SD, Pham H, Platt SM, Rao LJ, Schartman JP, Singerman LJ, Donkor R, Fink M, McCoy J, Karcher H. Coney JM, et al. Among authors: karcher h. Int J Retina Vitreous. 2023 Feb 1;9(1):8. doi: 10.1186/s40942-023-00445-0. Int J Retina Vitreous. 2023. PMID: 36726178 Free PMC article.

4

RETINAL VASCULITIS OR VASCULAR OCCLUSION AFTER BROLUCIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Systematic Review of Real-World Evidence.

Wykoff CC, Matsumoto H, Barakat MR, Karcher H, Lozama A, Mayhook A, Oshagbemi OA, Zorina O, Hassan TS, Khanani AM, Heier JS. Wykoff CC, et al. Among authors: karcher h. Retina. 2023 Jul 1;43(7):1051-1063. doi: 10.1097/IAE.0000000000003769. Epub 2023 Jun 16. Retina. 2023. PMID: 36893438 Free PMC article.

5

Factors Linked to Injection Interval Extension in Eyes with Wet Age-Related Macular Degeneration Switched to Brolucizumab.

MacCumber MW, Wykoff CC, Karcher H, Adiguzel E, Sinha SB, Vishwakarma S, LaPrise A, Igwe F, Freitas R, Ip MS, Zarbin MA. MacCumber MW, et al. Among authors: karcher h. Ophthalmology. 2023 Aug;130(8):795-803. doi: 10.1016/j.ophtha.2023.03.017. Epub 2023 Mar 27. Ophthalmology. 2023. PMID: 36990322

6

Real-World Persistence and Treatment Interval in Patients with Diabetic Macular Edema Treated with Anti-Vascular Endothelial Growth Factors in the USA.

Bakri SJ, Delyfer MN, Grauslund J, Andersen S, Karcher H. Bakri SJ, et al. Among authors: karcher h. Ophthalmol Ther. 2023 Oct;12(5):2465-2477. doi: 10.1007/s40123-023-00750-9. Epub 2023 Jun 22. Ophthalmol Ther. 2023. PMID: 37347405 Free PMC article.

7

Real-World Safety Outcomes with Brolucizumab in Neovascular Age-Related Macular Degeneration: Findings from the IRIS® Registry.

Zarbin MA, MacCumber MW, Karcher H, Adiguzel E, Mayhook A, LaPrise A, Bilano VL, Igwe F, Ip MS, Wykoff CC. Zarbin MA, et al. Among authors: karcher h. Ophthalmol Ther. 2024 May;13(5):1357-1368. doi: 10.1007/s40123-024-00920-3. Epub 2024 Mar 23. Ophthalmol Ther. 2024. PMID: 38520643 Free PMC article.

8

Multimorbidities in COPD are Associated With Increased Exacerbations and Health Care Resource Utilization in Real-World Patients from a U.S. Database.

Krishnan JK, Martinez FJ, Altman P, Bilano VLF, Khokhlovich E, Przybysz R, Karcher H, Schoenberger M. Krishnan JK, et al. Among authors: karcher h. Chronic Obstr Pulm Dis. 2024 Sep 27;11(5):472-481. doi: 10.15326/jcopdf.2024.0515. Chronic Obstr Pulm Dis. 2024. PMID: 39133115 Free PMC article.

9

Impact of COVID-19 measures on exacerbation rates and healthcare visits in US asthma patients.

Karcher H, Schoenberger M, Rayban T, Kelly C, Heaney A, Mackay A. Karcher H, et al. Allergy Asthma Proc. 2023 Nov 1;44(6):422-428. doi: 10.2500/aap.2023.44.230061. Allergy Asthma Proc. 2023. PMID: 37919845 Free PMC article.

10

SARS-CoV-2 seroprevalence among people living with HIV in the German HIV-1 Seroconverter Cohort, 2020-2022.

Hohn O, Meixenberger K, Volkwein A, Körner K, Icli S, Koppe U, Hower M, Bremer V, Gunsenheimer-Bartmeyer B, Bannert N; German HIV-1 Seroconverter Study Group. Hohn O, et al. BMC Infect Dis. 2024 Nov 1;24(1):1228. doi: 10.1186/s12879-024-10119-3. BMC Infect Dis. 2024. PMID: 39487409 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

245 results

Search Page

Filters